NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP) today announced its operating results for the second quarter ended June 30, 2011. Service revenue for the second quarter of 2011 was $913,000, compared $805,000 in the second quarter of 2010. Service revenue for the first six months of 2011 was $1.7 million compared to $1.6 million for the first six months of 2010. The increase in revenue is from contracts relating to the Company’s Barrett’s esophagus technology and Biofield co-development agreements.
